Recent reviews explore best practices for hip osteoarthritis clinical trials
Medical Metrics, Inc. uses the latest research and insight from recognized thought leaders to guide our medical imaging services. Facing an More »
Clinical Trials
Improving a device’s reimbursement prospects
A medical device reimbursement strategy expert recently shared some of his top tips for successful clinical trial design.
FDA releases guidance on adaptive trial design
As technology evolves and medical devices change as a result, creating even more challenges for regulators, clinical trial designs must adapt to the emerging trends.
Best positioning for radiography of the knee in OA clinical trials
Drs. T.J. Mosher and G.E. Gold, two of MMI’s thought leaders, recently were published in a review of the best practices for knee OA imaging in clinical trials.
Patient preferences to be an increasing factor in medical device development
A new guidance document, “Patient Preference Information –Submission, Review in PMAs, HDE Applications, and De Novo Requests, and Inclusion in Device Labeling,” aims to allow patient perspectives to play a greater role in the regulatory process.
CROs support increasing demand for clinical evidence
With the proper consideration and a clear understanding of what you value in a CRO, it is possible to develop an outsourcing strategy that can get your product to market more efficiently and with greater evidence to support it.
Importance of quality clinical data grows as market becomes more competitive
A recent survey of industry professionals found that the medical device market is growing increasingly competitive, emphasizing the need for high-quality clinical trial data.
Considerations for selecting the optimal CRO
To identify the ideal CRO to meet the imaging needs of your trial, it is important to involve them at the very beginning of the process.
FDA releases guidance for foreign clinical trial data acceptance
Sponsors of extra-U.S. trials need to carefully monitor the FDA’s requirements for the submission of foreign data.
Health insurance group calls for new rules on medical devices
A major health insurers group has penned a letter to a U.S. Senator in criticism of the 510(k) approval pathway.
12